SENSEX 60,047.49
205.28 (0.34%)

NIFTY 50 17,891.4
66.15 (0.37%)

NIFTY BANK 39,281.75
42.1 (0.11%)

Dr Reddys Laboratories Ltd

NSE :DRREDDY BSE :500124 Sector : Pharmaceuticals

Buy, Sell or Hold DRREDDY? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

16 Aug
4297.80
(0.87%)

12 Aug
4260.80
(0.06%)

11 Aug
4258.30
(0.35%)

10 Aug
4243.30
(0.47%)

08 Aug
4223.35
(1.60%)

05 Aug
4156.85
(0.21%)

04 Aug
4147.95
(1.26%)

03 Aug
4096.30
(0.27%)

02 Aug
4085.40
(-0.61%)

01 Aug
4110.45
(0.49%)

29 Jul
4090.35
(-3.98%)

28 Jul
4260.05
(-0.61%)

27 Jul
4286.05
(1.76%)

26 Jul
4212.00
(-2.74%)

25 Jul
4330.55
(-0.98%)

22 Jul
4373.50
(0.05%)

21 Jul
4371.10
(-1.97%)

20 Jul
4458.75
(0.24%)

19 Jul
4447.90
(-0.41%)

18 Jul
4466.10
(-1.76%)

15 Jul
4546.00
(-0.64%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Neutral

Medium Term Investors

Bearish

Long Term Investors

Very Bearish

Moving Averages

5 DMA

Bullish

4255.81

10 DMA

Bullish

4187.42

20 DMA

Bullish

4258.6

50 DMA

Bearish

4309.45

100 DMA

Bullish

4251.63

200 DMA

Bearish

4366.19

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Aug 16, 2022 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	4379.8	4349.4	4313.26	-	-
R2	4349.4	4327.93	4308.1	4350.55	-
R1	4323.6	4314.67	4302.95	4325.9	4336.5
P	4293.2	4293.2	4293.2	4294.35	4299.65
S1	4267.4	4271.73	4292.65	4269.7	4280.3
S2	4237	4258.47	4287.5	4238.15	-
S3	4211.2	4237	4282.35	-	-

Key Metrics

EPS

102.69

P/E

41.84

P/B

3.87

Dividend Yield

0.7%

Market Cap

71,536 Cr.

Face Value

5

Book Value

1111.23

ROE

11.84%

EBITDA Growth

1,803.5 Cr.

Debt/Equity

0.17

Shareholding Pattern

	26.71%	Total Promoter Holding

	14.21%	Mutual Fund Holdings

	25.87%	FIIs

	21.96%	Non Institution

	10.72%	Insurance Companies

	0.28%	Custodians

	0.25%	Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Quaterly Results

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022
INCOME	5069.6	6017.1	5412.6	5607.3	6096.2
PROFIT	380.4	995.8	709.3	97	1189
EPS	22.95	60.03	42.75	5.84	71.64

Dr Reddys Laboratories Ltd Quaterly Results

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022
INCOME	3619.7	3941.5	3542.6	3783.4	4034
PROFIT	413.4	449	341.1	419.7	499.5
EPS	24.94	27.07	20.55	25.29	30.1

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
INCOME	12151	13904.6	15353.2	15959	14490.9	14477.7	16104.9	18170	20177.4	22453.8
PROFIT	1514.4	1945.62	2291.79	2071.62	1252.3	892.34	1849.63	2030.35	1954.44	2110.85
EPS	87.37	112.29	133.04	123.55	75.83	54.96	117.47	121.9	117.28	131.16

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
INCOME	8612.7	10050.1	10262.7	10645.6	10309.1	9614.9	10797.9	12693.5	14545.8	15276.8
PROFIT	1251.28	1926.89	1634.01	1320.26	1406.23	536.19	1274.22	2948.85	1849.38	1628.89
EPS	71.98	113.56	94.48	80.56	83.48	34.15	76.95	176.76	131.39	97.55

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
SOURCES OF FUNDS :
Share Capital	83.2	83.2	83.1	83	83	82.9	85.3	85.2	85.1	84.9
Reserves Total	19,289.3	17,755.2	15,616.3	13,994.1	12,488.6	12,179.2	12,484.5	9,767.9	7,780.1	6,284.2
Equity Application Money	-160.1	-196.7	-100.6	-53.5	0	0	0	0	0	0
Total Shareholders Funds	19,212.4	17,641.7	15,598.8	14,023.6	12,571.6	12,262.1	12,569.8	9,853.1	7,865.2	6,369.1
Secured Loans	0	0	178.7	60.9	69.3	70.7	85.7	86.2	104.7	88.2
Unsecured Loans	3,384.5	3,030.8	2,031.5	3,777.2	5,002.1	4,847.8	3,266.4	4,227.9	4,372.3	3,594
Total Debt	3,384.5	3,030.8	2,210.2	3,838.1	5,071.4	4,918.5	3,352.1	4,314.1	4,477	3,682.2
Other Liabilities	192.7	212.5	280	297.4	375	427.6	344.5	351.2	174.4	86.4
Total Liabilities	22,789.6	20,885	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7
APPLICATION OF FUNDS :
Gross Block	19,786.1	18,555.7	16,108.2	14,998.6	17,436.3	15,932.4	15,019.7	12,573.6	11,917.6	10,089.4
Less: Accumulated Depreciation	11,664.6	10,350	9,257.9	7,807.6	10,468.3	9,001.7	8,456.7	7,196.6	7,276.8	6,038.8
Net Block	8,121.5	8,205.7	6,850.3	7,191	6,968	6,930.7	6,563	5,377	4,640.8	4,050.6
Capital Work in Progress	1,293.4	1,565.1	1,535.1	2,933.5	3,470.5	3,324.5	772.2	529	638.8	565.3
Investments	2,615.9	2,211.8	2,677.8	2,587.1	2,298.3	2,109.7	3,833.1	2,247.8	1,066.8	197
Inventories	5,088.4	4,541.2	3,506.7	3,357.9	2,908.9	2,852.8	2,557.9	2,569.9	2,418.8	2,170.7
Sundry Debtors	6,676.4	4,964.1	5,027.8	3,986.9	4,052.7	3,798.6	4,125	4,101.2	3,325.3	3,180.4
Cash and Bank Balance	2,419.2	2,078.8	205.3	222.8	263.8	386.5	492.1	1,872.4	2,300.6	2,017.1
Loans and Advances	1,581	1,587.7	1,490.6	1,289.6	1,440	1,218.7	1,115.6	1,231	1,214.6	961.9
Total Current Assets	15,765	13,171.8	10,230.4	8,857.2	8,665.4	8,256.6	8,290.6	9,774.5	9,259.3	8,330.1
Current Liabilities	5,825.1	5,062.6	4,610.2	3,762.2	3,739.6	3,385.6	3,304.6	2,794.8	2,573.2	2,568.4
Provisions	1,130.8	640.3	524.1	497	591.7	660.7	759.4	1,143.9	815.7	674.1
Total Current Liabilities & Provisions	6,955.9	5,702.9	5,134.3	4,259.2	4,331.3	4,046.3	4,064	3,938.7	3,388.9	3,242.5
Net Current Assets	8,809.1	7,468.9	5,096.1	4,598	4,334.1	4,210.3	4,226.6	5,835.8	5,870.4	5,087.6
Deferred Tax Assets	1,277	1,068.6	1,219.9	431.7	540.5	678.4	590.5	260.5	191.7	174.2
Deferred Tax Liability	1.4	28.9	2	47.3	195	162	53.7	156.2	124.1	107
Net Deferred Tax	1,275.6	1,039.7	1,217.9	384.4	345.5	516.4	536.8	104.3	67.6	67.2
Other Assets	674.1	393.8	711.8	465.1	601.6	516.6	334.7	424.5	232.2	170
Total Assets	22,789.6	20,885	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7
Contingent Liabilities	0	0	0	138	277.57	102.17	92.17	190	221.6	112.6

	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
SOURCES OF FUNDS :
Share Capital	83.2	83.2	83.1	83	83	82.9	85.3	85.2	85.1	84.9
Reserves Total	18,413.1	17,097.2	15,209.4	12,654.6	11,724.8	11,517.7	11,993.1	10,548.8	9,243.9	7,698.5
Equity Application Money	-160.1	-196.7	-100.6	-53.5	0	0	0	0	0	0
Total Shareholders Funds	18,336.2	16,983.7	15,191.9	12,684.1	11,807.8	11,600.6	12,078.4	10,634	9,329	7,783.4
Secured Loans	0	0	19.3	0	0	0	0.9	1.4	1.7	4.7
Unsecured Loans	2,205.4	1,214.5	1,437.6	1,064.6	2,588.8	2,355.2	3,084.2	3,124.7	2,664.5	2,095.3
Total Debt	2,205.4	1,214.5	1,456.9	1,064.6	2,588.8	2,355.2	3,085.1	3,126.1	2,666.2	2,100
Other Liabilities	94.6	67.9	84.1	83.2	84.6	103.4	123.6	75.3	38.2	32.6
Total Liabilities	20,636.2	18,266.1	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916
APPLICATION OF FUNDS :
Gross Block	13,349.1	12,345	10,215.9	9,774.1	9,223.6	8,675.4	7,580	5,815.6	4,899.7	4,208.7
Less : Accumulated Depreciation	7,198.6	6,500.7	5,782	5,091.4	4,506.3	3,833.3	3,141.9	2,566.2	2,151.4	1,821.7
Net Block	6,150.5	5,844.3	4,433.9	4,682.7	4,717.3	4,842.1	4,438.1	3,249.4	2,748.3	2,387
Capital Work in Progress	1,200.3	900.8	411.8	400.1	675	540	616.1	488.3	576.1	423.2
Investments	4,936.7	4,649.2	5,485.5	3,933.5	3,636.5	3,101.9	5,076.1	3,862.3	2,806.5	2,379.2
Inventories	3,347.8	2,819.7	2,190.4	2,015.6	1,856.8	1,809.7	1,699.6	1,723.3	1,592.1	1,526.5
Sundry Debtors	4,945.4	4,080	4,638.7	3,717.7	4,203.8	4,405.4	3,889.5	4,711.7	4,561.5	2,963.9
Cash and Bank Balance	2,030.5	1,646.5	39.2	113.2	120.7	66.8	202.1	901.4	665.1	919.1
Loans and Advances	1,247.5	1,141	1,120	972.3	1,174.4	1,012.8	1,121.9	964.7	1,022.7	994.1
Total Current Assets	11,571.2	9,687.2	7,988.3	6,818.8	7,355.7	7,294.7	6,913.1	8,301.1	7,841.4	6,403.6
Current Liabilities	3,537.2	3,064.8	2,535.6	2,175.4	2,445.7	2,179.6	2,127.5	1,952.1	1,870	1,558
Provisions	322.2	298.7	207.3	184.7	173.4	208.4	170.6	539.5	479.5	421.4
Total Current Liabilities & Provisions	3,859.4	3,363.5	2,742.9	2,360.1	2,619.1	2,388	2,298.1	2,491.6	2,349.5	1,979.4
Net Current Assets	7,711.8	6,323.7	5,245.4	4,458.7	4,736.6	4,906.7	4,615	5,809.5	5,491.9	4,424.2
Deferred Tax Assets	440.7	582.1	867.3	214.1	346.5	382.8	306	35.7	23.1	32.5
Deferred Tax Liability	421.3	327.3	254.4	269.6	253.4	300.7	242.5	164.7	148.3	126.2
Net Deferred Tax	19.4	254.8	612.9	-55.5	93.1	82.1	63.5	-129	-125.2	-93.7
Other Assets	617.5	293.3	543.4	412.4	622.7	586.4	478.3	554.9	535.8	396.1
Total Assets	20,636.2	18,266.1	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916
Contingent Liabilities	0	0	0	316.2	305.37	102.17	92.17	1,231.9	1,605.2	1,740

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 2,810.8

Net Profit before Tax and Extr...	3,061.4
Depreciation	1,165.2
Interest (Net)	-0.7
P/L on Sales of Assets	-111.9
Prov. and W/O (Net)	937.4
P/L in Forex	-75.8
Total Adjustments (PBT and Ext...	1,875.4
Operating Profit before Workin...	4,936.8
Trade and 0ther Receivables	-1,701.2
Inventories	-532.8
Trade Payables	441.2
Total Adjustments (OP before W...	-1,382.3
Cash Generated from/(used in) ...	3,554.5
Direct Taxes Paid	-743.7
Total Adjustments(Cash Generat...	-743.7
Cash Flow before Extraordinary...	2,810.8
Net Cash from Operating Activi...	2,810.8

Cash from Investing Activity -2,565.4

Purchased of Fixed Assets	-438.9
Sale of Fixed Assets	331.6
Purchase of Investments	-8,897.2
Sale of Investments	7,777.1
Interest Received	87.3
Net Cash used in Investing Act...	-2,565.4

Cash from Financing Activity -242.2

Proceeds from Issue of shares ...	33.4
Proceed from Short Tem Borrowi...	352
Of Financial Liabilities	-78.5
Dividend Paid	-414.6
Interest Paid	-134.5
Net Cash used in Financing Act...	-242.2

Cash from Operating Activity 1,338.7

Net Profit before Tax and Extr...	2,223.8
Depreciation	814.3
Interest (Net)	-128.9
P/L on Sales of Assets	7.8
Prov. and W/O (Net)	16.3
P/L in Forex	-162.3
Total Adjustments (PBT and Ext...	583.1
Operating Profit before Workin...	2,806.9
Trade and 0ther Receivables	-865.5
Inventories	-528.1
Trade Payables	329.8
Total Adjustments (OP before W...	-979.4
Cash Generated from/(used in) ...	1,827.5
Direct Taxes Paid	-488.8
Total Adjustments(Cash Generat...	-488.8
Cash Flow before Extraordinary...	1,338.7
Net Cash from Operating Activi...	1,338.7

Cash from Investing Activity -1,990.1

Purchased of Fixed Assets	-1,365.6
Sale of Fixed Assets	9.4
Purchase of Investments	-9,111.8
Sale of Investments	8,272.6
Interest Received	157.4
Net Cash used in Investing Act...	-1,990.1

Cash from Financing Activity 505.5

Proceeds from Issue of shares ...	33.4
Proceed from Short Tem Borrowi...	968.3
Of Financial Liabilities	-17.2
Dividend Paid	-414.6
Interest Paid	-64.4
Net Cash used in Financing Act...	505.5

Dr Reddys Laboratories News

Torrent Pharma Shares in Focus as Stock Trades Ex-Bonus

July 8, 2022

Nifty Pharma Climbs 3% After RBI Announces Liquidity

May 5, 2021

Dr Reddy’s Laboratories Profit After Tax Surges 77% To Rs 504 Crores

October 29, 2018

Dr Reddy’s Sells Its Rights Of Cloderm Cream To EPI Health

October 3, 2018

Dr Reddy's Lab files lawsuit in the US District Court

May 28, 2018

Dr Reddy's Labs Q3 net profit declines 29% YoY

January 25, 2018

Company Details

Registered Office
Address	8-2-337 Road No 3, Banjara Hills
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Registrars
Address	8-2-337 Road No 3
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Management
Name	Designation
G V Prasad	Co-Chairman & Managing Directo
K Satish Reddy	Chairman
Kalpana Morparia	Independent Director
Bruce L A Carter	Independent Director
Sridar Iyengar	Independent Director
Prasad R Menon	Independent Director
Shikha Sanjaya Sharma	Independent Director
Allan Oberman	Independent Director
Leo Puri	Independent Director
K P Krishnan	Independent Director
Pennv Wan	Independent Director
K Randhir Singh	Company Sec. & Compli. Officer

Related Links

Dr Reddys Laboratories Ltd Historical Data

Dr Reddys Laboratories Ltd Technical Chart

Top Stocks - Pharmaceuticals

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

@2022 -Equitypandit Media Corp. All Right Reserved.